Talk:MG132

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

How about the clinical trail of MG132?[edit]

MG132 has good activity against proteasome, which could compare with PS341 (Bortezomib,VELCADE). However, there is no information about its progression in the clinical trial. Who knows why? Thanks! 202.127.26.2 (talk) 14:38, 18 January 2010 (UTC)[reply]

How about the peer reviewed article of MG132 activity?[edit]

Where is reference for the peer reviewed article that shows the activity of MG132? —Preceding unsigned comment added by 131.247.212.130 (talk) 23:23, 26 May 2010 (UTC)[reply]


Biological Activity of MG-132[edit]

There is a mismatch here! This paragraph is a copy of the similar paragraph of the Wikipedia page of Neratinib, but there are here no data about the MG-132! Revise, please! Thanks! — Preceding unsigned comment added by 178.48.1.37 (talk) 11:40, 16 August 2016 (UTC)[reply]

I agree that it appears to be a copy-and-pasted paragraph referring to a different chemical compound, so I have simply removed it. -- Ed (Edgar181) 13:05, 16 August 2016 (UTC)[reply]

Misleading information in the editing comment of 16 March 2018[edit]

As i cannot change the comment of my editation on March 16, 2018, I would like to apologize for a wrong information put in the comment. I wrote, that Calpain was one of the names of the proteasome. This was a stupid mistake of mine. It is not, but another non-lysosomal peptidase (not even a threonine-peptidase, but a cysteine-peptidases). So, if someone reads the editing history, please don't get confused by this comment, which should be corrected. Unfortunately, I do not know how. — Preceding unsigned comment added by Oeckes (talkcontribs) 09:09, 22 March 2018 (UTC)[reply]